National Lipid Association Scientific Sessions

Healio brings you the highlights from the National Lipid Association Scientific Sessions. Refer back to this page often for the latest news from NLA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting NewsVideo

VIDEO: Monogenic causes of CVD help identify therapeutic targets

May 24, 2017
In this Cardiology Today video exclusive, Nathan Stitziel, MD, PhD, discusses the potential of utilizing clinical genetic testing help diagnose and…
Meeting News

Multidisciplinary approach may lead to more insurance approvals for PCSK9 inhibitors

May 23, 2017
PHILADELPHIA — A multidisciplinary approach to prescribing PCSK9 inhibitors to patients resulted in a higher rate of insurance approvals…
Meeting News

Bempedoic acid may further reduce LDL when added to high-intensity statin therapy

May 22, 2017
PHILADELPHIA — Patients treated with bempedoic acid in addition to high-intensity statin therapy had a reduction in LDL, according to results…
Meeting News

Experts highlight important literature in lipidology

May 22, 2017
PHILADELPHIA — Nutrition, gene variants and familial hypercholesterolemia were the topics of three important journal articles discussed at the…
Meeting NewsVideo

VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations

May 22, 2017
PHILADELPHIA — In this Cardiology Today video exclusive, James A. Underberg, MD, MS, FACPM, FACP, FNLA, new president of the National Lipid…
Meeting News

Recent trials advance lipidology knowledge base

May 21, 2017
PHILADELPHIA — Numerous important trials in clinical lipidology have been reported over the last year, according to a presentation at the…
Meeting News

Diagnosis of Fredrickson-Levy-Lees dyslipidemias inconsistent

May 21, 2017
PHILADELPHIA — A variance in the two qualitative approaches to diagnose patients with Fredrickson-Levy-Lees dyslipidemias may explain the…
Meeting News

FOURIER: Evolocumab reduces CV events regardless of baseline LDL, statin intensity

May 21, 2017
PHILADELPHIA — A subanalysis of the FOURIER trial presented at the National Lipid Association Scientific Sessions found that evolocumab was…
Meeting News

PCSK9 inhibition reduces LDL in patients on top of other therapies

May 21, 2017
PHILADELPHIA — In a real-world cohort of patients on maximally tolerated lipid-lowering therapies, PCSK9 inhibitors lowered LDL by 26% to 52%…
Meeting News

PCSK9 inhibitors recommended by NLA for certain patient groups

May 20, 2017
PHILADELPHIA — A National Lipid Association expert panel prepared updated recommendations for the use of PCSK9 antibody therapy at the NLA

Meeting Calendar

National Lipid Association Scientific Sessions

May 18, 2017 - May 21, 2017

  • Location: Philadelphia, Pa.
  • Website
Advertisement
Advertisement